Brussels, 06/02/2009 (Agence Europe) - On Thursday 5 February 2009, the Commission authorised the proposed acquisition of the Czech generic pharmaceuticals firm Sentiva by Sanofi-Aventis Europe of France, a producer of originator medicines. To remedy the Commission's competition concerns in different therapeutic areas on a number of national markets, Sanofi-Aventis committed to divest 15 drugs in the Czech Republic, the Slovak Republic, Romania, Bulgaria, Hungary and Estonia. Generic...